IL17A and major depressive disorder: The KEGG enrichment analysis revealed that the AL compounds targeted multiple signaling pathways related to depression, which primarily include neuroactive ligand–receptor interaction, the calcium signaling pathway, dopaminergic synapse, the IL-17 signaling pathway, and the pathways of neurodegeneration.